PPH vs. RDIV
PPH (VanEck Pharmaceutical ETF) and RDIV (Invesco S&P Ultra Dividend Revenue ETF) are both exchange-traded funds - PPH is a Health & Biotech Equities fund tracking the MVIS US Listed Pharmaceutical 25 Index, while RDIV is a Mid Cap Value Equities fund tracking the S&P 900 Dividend Revenue-Weighted Index. Both are passively managed. Over the past 10 years, PPH returned 8.39%/yr vs 11.04%/yr for RDIV. A 0.50 correlation means they provide meaningful diversification when combined. PPH charges 0.36%/yr vs 0.39%/yr for RDIV.
Performance
PPH vs. RDIV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PPH achieves a 2.96% return, which is significantly lower than RDIV's 14.73% return. Over the past 10 years, PPH has underperformed RDIV with an annualized return of 8.39%, while RDIV has yielded a comparatively higher 11.04% annualized return.
PPH
- 1D
- -1.04%
- 1M
- 4.48%
- YTD
- 2.96%
- 6M
- 3.80%
- 1Y
- 18.69%
- 3Y*
- 12.38%
- 5Y*
- 9.47%
- 10Y*
- 8.39%
RDIV
- 1D
- -1.73%
- 1M
- 5.67%
- YTD
- 14.73%
- 6M
- 12.64%
- 1Y
- 29.81%
- 3Y*
- 18.46%
- 5Y*
- 10.99%
- 10Y*
- 11.04%
PPH vs. RDIV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PPH VanEck Pharmaceutical ETF | 2.96% | 22.00% | 8.05% | 6.95% | 2.64% | 17.79% | 5.49% | 19.39% | -5.89% | 15.23% |
RDIV Invesco S&P Ultra Dividend Revenue ETF | 14.73% | 12.36% | 15.17% | 4.66% | 7.16% | 29.12% | -9.31% | 22.62% | -4.78% | 11.63% |
Correlation
The correlation between PPH and RDIV is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.34 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.41 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.51 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.51 |
Correlation (All Time) Calculated using the full available price history since Oct 1, 2013 | 0.50 |
The correlation between PPH and RDIV shifts across timeframes, from 0.34 (1 year) to 0.51 (10 years), reflecting how their relationship changes across market environments.
PPH vs. RDIV - Sectors Allocation Comparison
Sectors
PPH
RDIV
Healthcare
Industrials
-
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
PPH
RDIV
Industrials
PPH
RDIV
-
Basic Materials
PPH
-
RDIV
Communication Services
PPH
-
RDIV
Consumer Cyclical
PPH
-
RDIV
Consumer Defensive
PPH
-
RDIV
Energy
PPH
-
RDIV
Financial Services
PPH
-
RDIV
Real Estate
PPH
-
RDIV
Technology
PPH
-
RDIV
Utilities
PPH
-
RDIV
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PPH vs. RDIV — Risk / Return Rank
PPH
RDIV
PPH vs. RDIV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Pharmaceutical ETF (PPH) and Invesco S&P Ultra Dividend Revenue ETF (RDIV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PPH | RDIV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.20 | ||
| Sortino ratioReturn per unit of downside risk | -1.63 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.39 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | 1.74 | 6.18 | -4.44 |
| Martin ratioReturn relative to average drawdown | 4.30 | 18.36 | -14.06 |
Loading charts...
Drawdowns
PPH vs. RDIV - Drawdown Comparison
The maximum PPH drawdown since its inception was -51.45%, roughly equal to the maximum RDIV drawdown of -49.97%. Use the drawdown chart below to compare losses from any high point for PPH and RDIV.
Loading charts...
Drawdown Indicators
| PPH | RDIV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.45% | -49.97% | -1.48% |
Max Drawdown (1Y)Largest decline over 1 year | -10.76% | -4.84% | -5.92% |
Max Drawdown (3Y)Largest decline over 3 years | -18.06% | -17.91% | -0.15% |
Max Drawdown (5Y)Largest decline over 5 years | -20.26% | -24.89% | +4.63% |
Max Drawdown (10Y)Largest decline over 10 years | -29.70% | -49.97% | +20.27% |
Current DrawdownCurrent decline from peak | -4.90% | -1.73% | -3.17% |
Average DrawdownAverage peak-to-trough decline | -17.29% | -5.85% | -11.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.45% | 1.63% | +2.82% |
Volatility
PPH vs. RDIV - Volatility Comparison
VanEck Pharmaceutical ETF (PPH) has a higher volatility of 5.95% compared to Invesco S&P Ultra Dividend Revenue ETF (RDIV) at 4.07%. This indicates that PPH's price experiences larger fluctuations and is considered to be riskier than RDIV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PPH | RDIV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.95% | 4.07% | +1.88% |
Volatility (6M)Calculated over the trailing 6-month period | 12.18% | 8.83% | +3.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.66% | 13.26% | +4.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.14% | 17.56% | -2.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.00% | 21.90% | -4.90% |
PPH vs. RDIV - Expense Ratio Comparison
PPH has a 0.36% expense ratio, which is lower than RDIV's 0.39% expense ratio.
Dividends
PPH vs. RDIV - Dividend Comparison
PPH's dividend yield for the trailing twelve months is around 2.05%, less than RDIV's 3.57% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PPH VanEck Pharmaceutical ETF | 2.05% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
RDIV Invesco S&P Ultra Dividend Revenue ETF | 3.57% | 3.94% | 4.08% | 3.93% | 3.44% | 3.31% | 4.93% | 3.84% | 4.32% | 4.26% | 2.20% | 4.49% |
Frequently Asked Questions
PPH and RDIV have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PPH has higher volatility (5.95%) compared to RDIV (4.07%). In terms of maximum drawdown, PPH dropped -51.45% vs RDIV's -49.97%.
On 10-year performance, RDIV leads with 11.04% vs 8.39% for PPH. On fees, PPH is cheaper at 0.36% per year. On volatility, RDIV has been the lower-risk option at 4.07%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, RDIV has performed better with a 11.04% return vs 8.39%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PPH is cheaper with a 0.36% expense ratio, compared with 0.39% for RDIV.
RDIV has the higher dividend yield at 3.57%, compared with 2.05% for PPH.
PPH is categorized as Health & Biotech Equities, while RDIV is Mid Cap Value Equities. PPH tracks MVIS US Listed Pharmaceutical 25 Index, while RDIV tracks S&P 900 Dividend Revenue-Weighted Index. They also come from different issuers: VanEck and Invesco. Their fees differ too: 0.36% for PPH and 0.39% for RDIV.
RDIV currently has the higher Sharpe Ratio (2.26 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PPH and RDIV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer